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Abstract
Painful diabetic neuropathy (PDN) is a common complication of diabetes mellitus and adversely affects the patients’ quality
of life. Evidence has accumulated that PDN is associated with hyperexcitability of peripheral nociceptive primary sensory
neurons. However, the precise cellular mechanism underlying PDN remains elusive. This may result in the lacking of
effective therapies for the treatment of PDN. The phenolic glucoside, gastrodin, which is a main constituent of the Chinese
herbal medicine Gastrodia elata Blume, has been widely used as an anticonvulsant, sedative, and analgesic since ancient
times. However, the cellular mechanisms underlying its analgesic actions are not well understood. By utilizing a
combination of behavioral surveys and electrophysiological recordings, the present study investigated the role of gastrodin
in an experimental rat model of STZ-induced PDN and to further explore the underlying cellular mechanisms.
Intraperitoneal administration of gastrodin effectively attenuated both the mechanical allodynia and thermal hyperalgesia
induced by STZ injection. Whole-cell patch clamp recordings were obtained from nociceptive, capsaicin-sensitive small
diameter neurons of the intact dorsal root ganglion (DRG). Recordings from diabetic rats revealed that the abnormal
hyperexcitability of neurons was greatly abolished by application of GAS. To determine which currents were involved in the
antinociceptive action of gastrodin, we examined the effects of gastrodin on transient sodium currents (INaT) and potassium
currents in diabetic small DRG neurons. Diabetes caused a prominent enhancement of INaT and a decrease of potassium
currents, especially slowly inactivating potassium currents (IAS); these effects were completely reversed by GAS in a dose-
dependent manner. Furthermore, changes in activation and inactivation kinetics of INaT and total potassium current as well
as IAS currents induced by STZ were normalized by GAS. This study provides a clear cellular basis for the peripheral analgesic
action of gastrodin for the treatment of chronic pain, including PDN.
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Introduction
Painful diabetic neuropathy (PDN) is a neurological disorder
that is a common complication of diabetes mellitus, and can affect
many aspects of life and severely limit patients’ daily life [1].
Globally, the prevalence of PDN is increasing to epidemic
proportions [2,3]. Patients with PDN frequently develop severe
chronic pain, which can occur as spontaneous pain, allodynia
(pain perception in response to normally non-painful stimuli) and
hyperalgesia (exaggerated pain sensations to normally painful
stimuli) [4,5]. Clinically, the pain conditions exhibited by PDN
patients can be extremely difficult to treat. Although this painful
signal is believed to originate in the peripheral nervous system, the
precise cellular mechanisms of chronic pain associated with PDN
remain poorly understood. Evidence has accumulated that
abnormal hyperexcitability of nociceptive primary sensory neu-
rons may contribute to the exaggerated pain associated with
diabetic neuropathy [6,7,8,9,10]. It is well known that voltage-
gated sodium and potassium channels are important regulators of
excitability in neurons and play a key role in eliciting action
potentials (APs) [11,12,13,14]. The transient sodium current (INaT)
is the principle inward current that elicits the upstroke of AP. It
has been shown that INaT is increased significantly in small-sized
dorsal root ganglion (DRG) neurons in streptozotocin (STZ)-
induced diabetic rats [8,10]. This enhanced INaT is strongly
supported by the upregulated expression of the sodium channel
subunits, Nav1.7 and Nav1.8, in both small DRG neurons and
peripheral nociceptive fibers [8,10]. Potassium currents regulate
neuronal excitability by affecting the resting membrane potential
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[15,16]. In contrast to the well-studied INaT, the role of potassium
currents in regulating the hyperexcitability of small DRG neurons
in diabetic states has rarely been examined. Recently, a study by
Cao et al reported that the density of potassium currents was
markedly reduced in dissociated medium- and large-, but not
small-diameter DRG neurons in diabetic rats [17]. However, it
has been shown that once dissociated, small DRG neurons exhibit
different properties compared to neurons of the intact DRG
[18,19]. Therefore, we wished to establish whether and how
potassium currents are altered in the intact small DRG neurons
following STZ-induced diabetes.
4-Hydroxybenzyl alcohol 4-O-beta-D-glucopyranoside, which
is also known as gastrodin (GAS), is the main, active constituent
isolated from Gastrodia elata Blume (Orchidaceae). The molecular
formula of GAS is C13H18O7, and has a molecular weight of
286.28 [20]. The molecular structure of GAS is shown in Fig. 1.
Since ancient times in China, GAS was widely used clinically as an
anticonvulsant, an analgesic, and a sedative that was effective
against vertigo, general paralysis, epilepsy and tetanus [21,22,23].
Furthermore, recent in vitro studies found that GAS exerts a
neuroprotective action by attenuating glutamate accumulation
during transient focal cerebral ischemia [24,25,26]. There are
numerous reports showing that GAS may improve learning and
facilitate memory consolidation and retrieval [27,28]. GAS was
also reported to display anti-inflammatory properties by inhibiting
the expression of proinflammatory cytokines in microglial cells
[29]. Despite these observations, the precise mechanisms respon-
sible for the analgesic action of GAS in pathological pain states
have not been examined.
In the present study, we first attempted to elucidate the
contribution of potassium currents to the hyperexcitability of small
DRG neurons in diabetic rats and then to probe the cellular
mechanisms by which GAS alleviates the enhanced pain induced
by STZ. We systematically demonstrated that diabetes caused a
prominent downregulation of potassium currents, an upregulation
of sodium currents, and significantly changed their activation and
inactivation properties in small DRG neurons. Administration of
GAS effectively attenuated the allodynia and hyperalgesia-related
to the experimental diabetes by reciprocal regulation of sodium
and potassium currents in small DRG neurons.
Results
Development of Thermal Hyperalgesia, Mechanical
Allodynia and Hyperglycemia in STZ-injected Rats
Consistent with our previous report [10], most of the rats
(.80%) developed hyperglycemia (2962 mM, n=15) following
STZ injection. This hyperglycemia started on the 3
rd day after
STZ and persisted during the entire experimental period (Fig. 2A,
left panel). In contrast, control rats that received saline injections
maintained normal blood glucose levels (761 mM, n=15, Fig. 2A,
left panel). Compared to control rats, diabetic rats developed
mechanical allodynia, which was manifested as a significant
decrease in response threshold to von Frey filaments application to
the hindpaws (Fig. 2A, middle panel). In parallel, a dramatic drop
in response latency to noxious plantar heat stimuli, reflecting
thermal hyperalgesia, was found in diabetic rats (Fig. 2A, right
panel).
GAS Inhibits Mechanical Allodynia and Thermal
Hyperalgesia, but Not Hyperglycemia in Diabetic Rats
To investigate the effect of GAS on diabetic painful neuropathy,
we performed experiments in which GAS was intraperitoneally
(i.p.) administered to rats for 12 days beginning 12 d after the STZ
injection. As shown in Fig. 2B, administration of GAS significantly
attenuated the development of mechanical allodynia in a dose-
dependent manner in diabetic rats. Quantitative analysis showed
that GAS increased the mechanical pain threshold to 4.761.0 g,
9.561.2 g and 11.361.3 g at doses of 5, 10 and 20 mg/kg body
weight, respectively, as compared to vehicle treatment
(10.161.1 g) when tested 24 d after STZ injection (Fig. 2B, left
panel, P,0.05, n=15 vs 15). The dose-response curve was fitted to
a Hill equation, which yielded an EC50 of 7.960.2 mg/kg for
GAS (Fig. 2B, right panel). Similarly, the STZ-induced thermal
hyperalgesia was dramatically reduced by GAS in a dose-
dependent manner. Compared to the thermal latency for the
vehicle group (7.6561.1 s), the thermal latency was prolonged to
11.061.1 s, 14.561.4 s, and 18.461.6 s by GAS at doses of 5, 10
and 20 mg/kg body weight, respectively, when tested 24 d after
STZ injection (Fig. 2C, left panel, P,0.05, n=15 vs 15). The dose-
response curve revealed an EC50 of 8.160.3 mg/kg for GAS
(Fig. 2C, right panel). In contrast, mechanical and thermal
nociception in normal rats was not altered by the same
concentrations of GAS (Fig. 2D, P.0.05, n=5). Despite dramatic
inhibition of diabetic hyperalgesia, GAS did not exert a significant
effect on the development of hyperglycemia (Fig. 2E, P.0.05,
n=12).
GAS Alters Active Membrane Properties and Excitability
of Capsaicin-sensitive DRG Neurons from Diabetic Rats
To explore the mechanism by which GAS alleviates diabetic
hyperalgesia, we analyzed the effect of GAS on membrane
properties and excitability of capsaicin-sensitive DRG neurons in
diabetic rats. Consistent with our previous study [10], the active
membrane properties of capsaicin-sensitive DRG neurons from
diabetic rats exhibited significant differences compared with
control rats. Table 1 illustrates the augmentation of excitability
Figure 1. Structures of 4-hydroxybenzyl alcohol 4-O-beta-D-
glucopyranoside (gastrodin or GAS).
doi:10.1371/journal.pone.0039647.g001
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increased AP amplitude, shorter AP half-width and greater AP
slope as well as lowered spike threshold were measured (Table 1,
P,0.05, n=35). However, the passive membrane properties of
small DRG neurons were not different between the control and
diabetic groups (Table 2, P,0.05, n=35). Bath application of
GAS (300 mM) significantly decreased the excitability of small
DRG neurons recorded from diabetic animals (Table 1, P,0.05,
Figure 2. Analgesic effect of GAS on the mechanical allodynia and thermal hyperalgesia induced by STZ injection. (A) (left) Average
random blood glucose levels in control (n=15) and diabetic rats (n=15) for up to 35 d after STZ injection. The rats developed hyperglycemia from
the 3
rd day after STZ injection. (middle and right) Mechanical allodynia and thermal hyperalgesia developed in diabetic rats (n=20) but not control
rats (n=20). Note that mechanical paw withdrawal threshold (PWT) and thermal paw withdrawal latency (PWL) were reduced from 3
rd day following
STZ injection. (B, C) Intraperitoneal administration of GAS (5, 10 and 20 mg/kg body weight) attenuated mechanical allodynia (B) and thermal
hyperalgesia (C) induced by STZ in a dose-dependent manner (n=15). Concentration-response curves of GAS on mechanical allodynia and thermal
hyperalgesia are shown in the right panels of (B) and (C), respectively. (D) The same concentrations of GAS were not effective on basal mechanical
(left panel) and thermal (right panel) nociception in control rats (n=5). (E) GAS did not exert any obvious effect on the hyperglycemia in diabetic rats.
All data are represented as mean 6 SEM. * represents a significant difference between diabetic and control groups (n=12) by a one-way ANOVA.
+ represents a significant difference between diabetic groups and diabetic + GAS groups by a one-way ANOVA.
doi:10.1371/journal.pone.0039647.g002
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spike threshold in diabetic DRG neurons was normalized by GAS
(Table 1, P,0.05, n=25). More importantly, the mean firing
frequency induced by a depolarizing current step was much higher
in small DRG neurons from diabetic rats than that from control
rats (Fig. 3A, B, P,0.05, n=10 vs 8). This elevated firing
frequency was markedly reduced by application of GAS (300 mM)
(Fig. 3A, B, P,0.05, n=7 vs 10). Further analysis of the latency for
the first spike revealed that diabetic rats showed a much shorter
latency for the first spike elicited by the same intensity of
stimulation compared to controls (Fig. 3A, B, P,0.05, n=10 vs 8).
This shortened latency in diabetic rats was normalized to control
levels by GAS (Fig. 3A, B, P,0.05, n=7 vs 10). The passive
membrane properties of diabetic small DRG neurons was,
however, not altered by GAS (Table 2, P.0.05, n=25). In
striking contrast to the dramatic effect of GAS on diabetic DRG
neurons, the same concentrations of GAS did not exert obvious
effects on the active and passive membrane properties as well as
firing frequency to depolarizing currents in control DRG neurons
(Table 1, Fig. 3A and B, P.0.05, n=6). At the end of the
experiment, capsaicin (1 mM) was bath applied to confirm that the
recorded neurons were capsaicin responsive (i.e., membrane
depolarization). Additionally, GAS did not alter the passive and
active membrane properties and firing frequency of capsaicin-
insensitive small DRG neurons from diabetic rats (Table 3, 4,
P.0.05, n=7).
GAS Inhibits INaT in Capsaicin-sensitive DRG Neurons
from Diabetic Rats
The inward transient sodium current (INaT) is the principal
component of an action potential [11,12]. To record the total INaT
in small DRG neurons (soma diameter ,30 mm, cell capacitance
,45 pF), cells were held at –60 mV and then imposed voltage
commands of depolarizing test pulses from 280 mV to +50 mV
300 ms in duration were preceded by a 700 ms prepulse to
2110 mV [8,30]. Figure 4A shows representative current traces of
total INaT in small DRG neurons from diabetic and control rats.
The peak amplitude of INaT in the diabetic group was significantly
increased compared to the control group (Fig. 4A, P,0.05, n=30
vs 25). The increase in INaT exhibited by diabetic DRG neurons
was dose-dependently inhibited by bath application of GAS
(100 mM–1 mM); the inhibition was also reversible (Fig. 4B, C,
P,0.05, n=10). Figure 4D shows the concentration-response
curve fitted by a Hill function, which yielded an IC50 of
0.2460.003 mM for GAS.
Voltage-dependent activation and inactivation are physiologi-
cally important characteristics of ion channels that can directly
influence the excitability of neurons. As shown in Fig. 4E, the I-V
relations of INaT determined from diabetic DRG neurons was
shifted ,10 mV in the hyperpolarizing direction compared to
control neurons. This shift was eliminated by administration of
GAS (300 mM) to diabetic DRG neurons (Fig. 4E, P,0.05, n=6).
The voltage-dependence of activation and inactivation of INaT
were calculated and fitted with Boltzmann equation as shown in
Fig. 4F. The midpoint (V1/2) for activation of INaT was shifted
leftward in the diabetic group (230.362.5 mV, n=6) compared
to the control group (220.462 mV, n=8) (Fig. 4F, P,0.05).
Following treatment of diabetic DRG neurons with GAS, the V1/2
for activation of INaT returned to 221.161.1 mV, which is
comparable with that of control group (Fig. 4F, n=6). Similarly,
the inactivation relation for INaT was found to shift in the
hyperpolarizing direction in DRG neurons from diabetic rats
compared to control rats (Fig. 4F, P,0.05, n=6). However, this
deviation of inactivation curve of INaT in diabetic rats was not
affected by GAS (Fig. 4F, P.0.05, n=7). Analysis of the time
constants for activation and inactivation for INaT revealed that
both values were significantly reduced in diabetic DRG neurons
compared to controls (Fig. 4G, P,0.05, n=8 vs 8). These reduced
time constants were consistently increased by GAS administration
(300 mM) (Fig. 4G, P,0.05, n=6). In striking contrast to the
remarkable inhibition of INaT in diabetic DRG neurons, the same
concentrations of GAS did not exert obvious effect on INaT in
control DRG neurons (Fig. 4H, P.0.05, n=5).
To confirm that the recorded neurons were capsaicin-sensitive
DRG neurons, biocytin was infused into the recorded neuron
enabling the identification of the recorded neurons. Double
immunofluorescence staining experiments shown in Fig. 4I
demonstrated a recorded neuron which is TRPV1-positive,
indicating the potential nociceptive nature of the tested neuron
(Fig. 4I).
Table 1. The effect of GAS (300 mM) on active membrane properties of capsaicin-sensitive DRG neurons.
n
AP
Amplitude
(mV)
AP
half-width
(ms)
AP
max-rise slope
(mV/ms)
AP
max-decay slope
(mV/ms)
AP
threshold
(mV)
Control 30 98.57±2.94 2.77±0.21 96.18±5.37 –87.45±5.14 –26.67±2.29
Control + GAS 6 98.46±4. 71 2.83±0.44 96.41±7.91 –98.73±11.41 –22.48±4.56
Diabetic 35 115.39±3.29* 2.01±0.18* 124.23±11.55*– 72.32±8.43*– 37.39±2.68*
Diabetic + GAS 25 92.32±2.85
# 2.36±0.20 98.77±5.21
# –98.52±6.54
# –22.56±2.32
#
*represents significant difference between control and diabetes.
#represents significant difference between GAS and diabetes.
doi:10.1371/journal.pone.0039647.t001
Table 2. The effect of GAS (300 mM) on passive membrane
properties of capsaicin-sensitive DRG neurons.
n
Membrane
potential (mV)
Cm
(pF) Rm (MV)
Control 30 –53.28±3.41 32.8±3.03 372.21±32.67
Control + GAS 6 –56.75±3.09 36.6±4.55 318.6±49.79
Diabetic 35 –51.15±3.26 34.53±2.64 401.0±68.01
Diabetic + GAS 25 –52.63±2.79 33.81±4.12 360.17±71.59
doi:10.1371/journal.pone.0039647.t002
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dependent Potassium Currents in Capsaicin-sensitive
DRG Neurons
Apart from sodium currents, potassium currents are also
important for modifying the neural electrical properties and
excitability. Thus, we further investigated whether potassium
currents are affected in capsaicin-sensitive small DRG neurons
following STZ-induced diabetes. In the present study, we focused
on the total potassium current (total Kv current) and slowly
inactivating A-type current (IAS), which has also been termed ID,
IT,slow,o rIK(AT) in previous studies. However, it is not clear
whether all such currents are equivalent since differences have
been noted in activation voltage ranges, sensitivities to 4-
aminopyridine (4-AP) or tetraethylammonium (TEA), and the
dynamic properties of activation and inactivation. Nevertheless,
these currents can be identified by their activation and inactivation
properties, their dependence on holding potential, and sensitivity
to both 4-AP and a-Dentrotoxin (a-DTx) [16,31,32]. Previous
studies have reported that IAS is activated by depolarizing voltage
steps from hyperpolarized potentials and almost completely
inactivated when the membrane potential is held more positive
than 240 mV [9,13,33]. In the present experiments, IAS was
isolated using two different prepulse voltages. The cells were held
Figure 3. The inhibitory effect of GAS on the hyperexcitability of small DRG neurons in diabetic rats.( A) Representative traces showing
the spike firings in response to a depolarizing current step in capsaicin-sensitive small DRG neurons from control and diabetic rats. Note that the
traces before and after GAS application in each group were from the same neuron. (B) Quantitative analysis showing that GAS (n=7) at a
concentration of 300 mM remarkably reduced the increased firing frequency in diabetic small DRG neurons (upper panel) (n=10). The reduction of
the latency of first spike induced by STZ (n=10) was normalized by GAS (n=7, lower panel). * represents a significant difference between diabetic
and control groups by a Student’s t test.
# represents a significant difference between diabetic groups and diabetic + GAS groups by a paired-
samples t test. All data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0039647.g003
Table 3. The effect of GAS (300 mM) on active membrane properties of capsaicin-insensitive DRG neurons.
N
AP
Amplitude
(mV)
AP
half-width
(ms)
AP
max-rise slope
(mV/ms)
AP
max-decay
slope
(mV/ms)
AP
threshold
(mV)
Frequency
(Hz)
Control 4 113.98±5.73 2.26±0.47 123.18±20.35 –82.04±20.66 –23.65±3.78 5.98±2.69
Control + GAS 4 97.95±8.66 2.51±0.37 97.46±2.67 –62.68±15.51 –24.13±4.89 4.66±2.95
Diabetic 7 124.24±3.39 2.42±0.32 142.02±16.38 –75.37±9.98 –31.02±2.25 1 11.81±5.84
Diabetic + GAS 7 121.43±3.41 2.42±0.26 119.06±5.54 –76.13±10.18 –27.57±2.92 9.34±4.88
doi:10.1371/journal.pone.0039647.t003
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in 10 mV increments. By applying different prepulse potentials,
we could discriminate between total Kv current and IAS [34,35].
The total Kv current was obtained using a protocol with a 1 s
prepulse at 2120 mV. The sustained delayed rectifier (K-type)
current was recorded with a 1 s prepulse to 240 mV, which was
preceded by a test pulse. IAS was obtained by digital subtraction of
the K-type component from the total Kv current (Fig. 5A) [36,37].
All of our data are derived from capsaicin-sensitive neurons.
Figure 5A shows representative traces of potassium currents that
are differentiated by holding potentials. The average current
densities for total Kv and IAS were significantly reduced in the
diabetic group (n=24) compared with control group (n=22)
(Fig. 5B, P,0.05). The I-V relations of total Kv, including peak
and steady-state values further revealed a prominent decrease of
total Kv (measured from maximum amplitude to baseline) in
diabetic DRG neurons (upper panels of Fig. 5C, D, P,0.05,
n=18vs 12). The kinetics of activation of total Kv current were
calculated and demonstrated in the lower panels of Fig. 5C and D.
Diabetes caused a significant hyperpolarizing shift of ,7m Vi n
the V1/2 of activation for peak total Kv current (lower panel of
Fig. 5C, P,0.05, n=5), whereas the V1/2 of activation for steady-
state total Kv current was not significantly different between
diabetic neurons and control neurons (lower panel of Fig. 5D,
P.0.05, n=5). In addition, the activation time constant of total
Kv current was measured by fitting the activation phase of the
current traces with an exponential function raised to the second
power. As shown in the upper panel of Fig. 5E, diabetic neurons
display a much slower time constant for total Kv current
compared to control neurons, which ranged from 77.0610.1 ms
at 270 mV to 2.860.3 ms at +30 mV in diabetic neurons (n=8)
and 15.962.7 ms at 270 mV to 1.560.5 ms at +30 mV in
control neurons (n=6) (Fig. 5E, P,0.05). The decay phase of total
Kv current was best fitted by two exponential functions. The
inactivation time constant of total Kv current was plotted as a
function of membrane potential, as shown in the lower panel of
Fig. 5E. Diabetic neurons show a decrease in the slower
inactivation time constant for total Kv current at more hyperpo-
larizing membrane potentials, whereas the faster time constants
were not significantly different between the two groups of neurons
(lower panel of Fig. 5E, n=8 vs 6). In addition, the non-
inactivating potassium current was significantly decreased in the
diabetic groups (n=11) compared with controls (n=14) (Fig. 5B,
P,0.05).
The I-V curves for IAS are shown in Fig. 6A and B. Both the
peak and steady-state current densities of IAS were decreased in
DRG neurons from diabetic rats compared to control rats (Fig. 6
A, B, P,0.05, n=12 vs 14). The V1/2 of activation for peak IAS
was shifted by ,6 mV in the hyperpolarizing direction in diabetic
groups (Fig. 6C, P,0.05, n=12 vs 14), whereas there was no
significant difference in activation of steady-state IAS between
diabetic and control groups (Fig. 6D, P.0.05, n=11 vs 7). The
V1/2 of inactivation for IAS was 244.661.2 and 235.161.1 mV
in diabetic (n=10) and control (n=12) neurons, and the difference
between these values was significant (Fig. 6C, P,0.05). In parallel
with the decreased magnitude of IAS, the activation and
inactivation time constants of IAS were significantly different
between diabetic and control neurons. The activation time
constants were measured by fitting the rising phase of the current
traces with an exponential function raised to the second power.
Figure 6E shows the voltage dependence of the activation time
constant for IAS in the diabetic and control groups (P,0.05), which
was ,9.14 times slower in diabetic neurons (n=6) compared with
control neurons (n=5) over the same voltage range (Fig. 6E,
P,0.05). The relationship between the inactivation time constant
and membrane potential is demonstrated in Fig. 6F. The
inactivation time constant of IAS was also fitted by two exponential
functions. Although the slower time constant was significantly
faster in the diabetic group (Fig. 6F, P,0.05), the faster time
constant was not significantly different between the diabetic and
control groups (Fig. 6F, P.0.05).
GAS Enhances Potassium Currents in the Lower Voltage
Range only in Capsaicin-sensitive DRG Neurons
To further explore the cellular mechanisms underlying GAS-
induced analgesia in diabetic rats, we evaluated the effect of GAS
on potassium currents in capsaicin-sensitive DRG neurons. As
shown in Fig. 7A, bath application of GAS (100–1000 mM)
induced a dose-dependent increase of total Kv current recorded at
240 mV in small DRG neurons from diabetic rats. The
concentration-response curve of GAS on total Kv current was
calculated and fitted by a Hill function, which yielded an EC50 of
0.3960.007 mM (Fig. 7B, n=6). The I-V relations of peak total
Kv current in small DRG neurons from diabetic rats demonstrat-
ed that GAS (300 mM) prominently increased peak total Kv
current density at more negative membrane potentials, but
decreased current density at more positive potentials (Fig. 7C,
P,0.05, n=15). The V1/2 of activation for peak total Kv current
was shifted in a hyperpolarizing direction by GAS (Fig. 7C). In
addition, GAS also increased the amplitudes of the steady-state
total Kv current (Fig. 7D, P,0.05, n=8). In parallel, the time
constants for activation of total Kv current were significantly
reduced by GAS treatment (Fig. 7E, P,0.05, n=8). Additionally,
GAS diminished the amplitudes of the non-inactivating potassium
current at more depolarized potentials in diabetic neurons,
however GAS did not alter the current over the more hyperpo-
larized voltage range (Fig. 7F, n=8). In striking contrast, the same
concentrations of GAS did not cause any changes in potassium
currents in capsaicin-sensitive neurons from control rats (Fig. 7G,
P.0.05, n=7).
We also determined the effect of GAS on the amplitude,
activation and inactivation properties of IAS. As shown in Fig. 8A,
theI-VcurveforthepeakIASrevealedaprominentincreaseofIASby
GAS (300 mM) in the hyperpolarized range, but a decrease in the
depolarized voltage range (left panel of Fig. 8A, P,0.05, n=11).
Analysis of the voltage-dependent activation of the peak IAS
indicated that GAS (300 mM) caused a significant hyperpolarizing
shift (right panel of Fig. 8A, P,0.05, n=10). The V1/2 for
inactivation of IAS was approximately 238.3 mV in the GAS-
treated diabetic group which was at a more positive voltage than
vehicle-treated group (right panel of Fig. 8A, P,0.05, n=6). In
parallel, the time constants of activation for IAS were significantly
reduced by GAS application (Fig. 8B, P,0.05, n=6). In addition,
Table 4. The effect of GAS (300 mM) on passive membrane
properties of capsaicin-insensitive DRG neurons.
n
Membrane
potential (mV) Cm (pF) Rm (MV)
Control 4 –55.75±2.14 34.54±2.54 283.75±37.65
Control + GAS4 –54. 51±1.65 37.57±4.35 305.50±38.30
Diabetic 7 –54.47±2.74 33.65±5.20 357.66±68.76
Diabetic +
GAS
7 –55.03±3.16 35.37±5.83 309.61±62.71
doi:10.1371/journal.pone.0039647.t004
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39647Figure 4. GAS inhibited INaT in capsaicin-sensitive DRG neurons from diabetic rats. (A) Representative traces of INaT recorded from a
control (upper panel) and diabetic (lower panel) small DRG neuron. The protocol to record INaT is shown at the bottom. (B) Representative traces of
INaT show that GAS (100, 300, 500 mM, and 1 mM) reversibly produced a prominent inhibition of INaT in diabetic small DRG neurons. (C) Quantitative
analysis shows that inhibition of the peak current densities of INaT by GAS was dose-dependent (n=10). (D) Concentration-response curve of GAS on
INaT yielded an EC50 of GAS at 0.2460.003 mM (n=8). (E) I-V relations of INaT in small DRG neurons from control (n=25, open circles), diabetic (n=30,
filled circles) and diabetic +300 mM GAS (n=10, open triangles) groups. Note that I-V curves shifted leftward in diabetic rats and GAS treatment
eliminated this shift. (F) The voltage-dependent activation and the steady-state inactivation curves of INaT in small DRG neurons from control (n=8
and 6, blue), diabetic (n=6 and 7, black) and diabetic + GAS (n=6 and 7, red) groups. (G) The time constants of activation (left panel) and inactivation
(right panel) of INaT are plotted as a function of membrane potentials. Both time constants were significantly decreased in diabetic neurons (n=8).
This alteration was reversed by GAS (300 mM) (n=6). (H) GAS has no effect on INaT in control DRG neurons (n=5). (I) Double immunofluorescent
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39647staining shows that the biocytin-containing recorded neuron (arrow, red, left panel) is TRPV1-immunoreactive (green, middle panel). Scale bar:
100 mm. *represents a significant difference between diabetic and control groups by a one-way ANOVA.
#represents a significant difference between
diabetic groups and diabetic + GAS groups by a one-way ANOVA. All data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0039647.g004
Figure 5. Diabetes reduced total Kv current in capsaicin-sensitive DRG neurons. (A) Representative traces of potassium currents were
evoked by 700 ms depolarizing commands from 0 mV to 50 mV. These panels show total Kv current (a), non-inactivating potassium current (b) and
IAS (a-b), respectively. The holding potential was 280 mV. The total Kv current (a) was recorded with a 1s prepulse to 2120 mV. The non-inactivating
potassium current was obtained by a test pulse preceded by a 1 s prepulse to 240 mV. IAS is the difference current between (a) and (b). (B) The
histogram shows that the peak amplitude of total Kv current and IAS (n=24 vs 22) as well as the non-inactivating potassium current (n=11 vs 14) was
greatly reduced after diabetes (P,0.05). (C) I-V relations (upper panel) and voltage-dependent activation curves (lower panel) of peak total Kv current
were evaluated from diabetic (n=18 and 5, filled circles) and control (n=12 and 5, opened circles) neurons. (D) I-V relations (upper panel) and
voltage-dependent activation curves (lower panel) of steady-state total Kv current are shown. (E) The time constants for the activation of total Kv
current (upper panel) are plotted as a function of membrane potential (n=8 vs 6). In the lower panel, the time constants of inactivation are plotted as
a function of membrane potential. t1 is the slower time constant. t2 is the faster time constant. * represents a significant difference between diabetic
and control groups by a one–way ANOVA. All data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0039647.g005
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(300 mM) over each voltage range (left panel of Fig. 8C, P,0.05,
n=9). Application of GAS produced a hyperpolarizing shift of
,19 mV in the V1/2 of activation for steady-state IAS current (right
panel of Fig. 8C, P,0.05, n=6). However, the time constants for
inactivation of the total Kv or IAS current were not significantly
Figure 6. Diabetes reduced the slowly inactivating A-type current (IAS) in capsaicin-sensitive neurons. (A, B) I-V relations were obtained
for peak (A) and steady-state (B) IAS from diabetic (n=12, filled circles) and control (n=14, open circles) small DRG neurons. (C) The voltage-
dependent activation and inactivation curves for peak IAS from diabetic (n=12 and 10, filled circles) and control (n=14 and 12, open circles) neurons
are shown. (D) The voltage-dependent activation curve for steady-state IAS from diabetic (n=11, filled circles) and control (n=7, open circles) neurons
are displayed. (E) The activation time constant tm of IAS from diabetic (n=6, filled circles) and control (n=5, open circles) neurons was measured. The
time constants of IAS were increased in diabetic neurons. (F) The inactivation time constants (t1, t2)o fIAS from diabetic (n=6, filled circles) and control
(n=5, open circles) neurons are plotted. t1 is the slower time constant. t2 is the faster time constant. * represents a significant difference between
diabetic and control groups by a one–way ANOVA. All data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0039647.g006
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e39647Figure 7. GAS increased the total Kv current in capsaicin-sensitive diabetic neurons. (A) The original traces of potassium currents, elicited
at 240 mV, were obtained before and after a series of concentrations of GAS. With increasing GAS doses, the peak values of total Kv current were
gradually elevated. (B) Percentage of elevated Kv current is plotted as a function of GAS concentration (n=6). (C) I-V relations (left panel) and the
voltage-dependent activation curves (right panel) of peak total Kv current were obtained from diabetic (n=18 and 12, filled circles) and GAS neurons
(n=10 and 10, open triangles). The histogram (right panel) indicates that 300 mM GAS (n=15) increased the amplitude of total Kv current when the
membrane potential was held at 240 mV, but decreased this current at 40 mV. (D) The current density of steady-state total Kv current (left panel) is
plotted as a function of membrane potential. The voltage-dependent activation curves of steady-state total Kv current are shown in the right panel.
(E) The activation time constants for total Kv current are plotted as a function of membrane potential. Treatment with GAS (300 mM) significantly
reduced the activation time constants (n=8). (F) The histogram indicates that 300 mM GAS (n=8) reduced the amplitude of non-inactivating current
when the membrane potential was held at 40 mV, but did not alter this current at 240 mV. (G) GAS did not alter the potassium currents in capsaicin-
sensitive neurons from control rats (n=7). * represents a significant difference between diabetic and diabetic + GAS groups by a one-way ANOVA. All
data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0039647.g007
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shown).
Discussion
By utilizing a combination of behavioral surveys and electro-
physiological recordings, we demonstrated for the first time the
analgesic action of GAS in an experimental rat model of painful
diabetic neuropathy induced by STZ injection. GAS exerts this
analgesic effect by reversing both the increased INaT and the
reduced total potassium and IAS currents measured in the diabetic
states.
GAS Inhibits Diabetes-induced Allodynia and
Hyperalgesia
Following STZ injection, about 87% of the rats developed
hyperglycemia. The sensitivity of diabetic rats with hyperglycemia
to mechanical and thermal stimuli was tested wherein 90% of rats
with hyperglycemia developed mechanical allodynia and thermal
hyperalgesia. This pain hypersensitivity started on the 4
th day after
STZ and remained throughout the entire testing phase. These
results are consistent with previous reports and indicate that the
STZ-induced diabetic animal model successfully simulates the
pathophysiology of PDN [7,8,38,39,40]. One of the most striking
findings of the present study is that intraperitoneal injection of
GAS, a main constituent of the traditional Chinese herb Tianma
(Gastrodia elata Blume) effectively attenuated the allodynia and
hyperalgesia associated with diabetic neuropathy. In contrast, the
same concentrations of GAS did not exert any obvious effects on
basal nociception. Taken together, these results suggest that GAS
may selectively inhibit pathological pain but not physiological
pain. Since ancient times in China, GAS has been widely used in
clinical trials of a number of conditions including vertigo, epilepsy,
general paralysis and tetanus [21,22,23]. As an analgesic, GAS has
been reported in clinical trials to be effective in relieving trigeminal
neuralgia, migraine and vascular headache [41,42,43]. However,
experimental data systematically examining the role of GAS on
animal pain models and its underlying cellular mechanisms has
not been reported.
GAS Inhibits the Enhanced INaT in Small DRG Neurons
from Diabetic Rats
To explore the cellular mechanisms underlying GAS-induced
analgesia in diabetic rats, we used an in vitro intact DRG
preparation to perform whole-cell patch clamp recordings in
capsaicin-sensitive small DRG neurons. These neurons are known
to play a crucial role on pain hypersensitivity following injury or
inflammation. A growing body of evidence has shown that acute
dissociation by itself produces an abnormal hyperexcitability of
DRG neurons, which is similar to changes in DRG neurons
produced by injury in the intact animals [18,19,44,45,46].
Therefore, in the present study, we used intact DRG preparations,
which are much closer to the native physiological state than
acutely dissociated DRG neurons for further study. In comparison
with controls, small DRG neurons in diabetic rats displayed
enhanced excitability which was manifested as increased AP
amplitude, shorter AP half-width, greater AP slope and lowered
spike threshold as well as increased firing frequency to a
Figure 8. GAS increased the slowly inactivating A-type currents (IAS) in capsaicin-sensitive diabetic DRG neurons. (A) I-V relations (left
panel) and voltage-dependent activation and inactivation curves (right panel) for peak IAS were obtained from capsaicin-sensitive DRG neurons in
diabetic (n=12, 12 and 10, filled circles) and diabetic + GAS groups (n=11, 10 and 6, open triangles). (B) The activation time constants tm of IAS were
measured in diabetic (n=6, filled circles) and diabetic + GAS (n=6, open triangles) groups. (C) I-V relations (left panel) and the voltage-dependent
activation curves (right panel) for steady-state IAS were obtained from diabetic (n=11, filled circles) and diabetic + GAS (n=6, open triangles) groups.
The activation curve was significantly shifted leftward after GAS treatment. * represents a significant difference between diabetic and diabetic + GAS
groups by a one-way ANOVA. All data are represented as mean 6 S.E.M.
doi:10.1371/journal.pone.0039647.g008
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others’ previous studies [8,10]. Excitingly, this augmentation of
excitability in diabetic DRG neurons can be normalized by bath
application of GAS. This suggests that the GAS-induced blockade
of hyperexcitability of capsaicin-sensitive small DRG neurons
might partially mediate the analgesic effect of GAS in diabetic rats.
To further investigate the mechanisms by which GAS
diminishes excitability of diabetic DRG neurons, we examined
the effect of GAS on INaT, which is a crucial component for
regulating neuronal excitability [12,47]. Consistent with previous
studies [8,10], we found that the peak current density of INaT was
much greater in diabetic small DRG neurons compared to control
neurons. This enhancement of INaT was also seen in other animal
pain models [30,47,48,49]. Further analysis of activation and
inactivation properties of INaT revealed a significant difference
between diabetic and control groups. Treatment with GAS
dramatically reduced the magnitude of INaT in a reversible
manner. This inhibitory effect of GAS was dose-dependent. The
differences in the activation curves of INaT in diabetic rats
compared to control rats were eliminated by administration of
GAS. Furthermore, GAS normalized the reduction of activation
and inactivation time constants of INaT in diabetic DRG neurons.
In striking contrast, the same concentrations of GAS used in
diabetic rats had no effect on INaT in control rats. We infer from
the above that inhibition of GAS on the abnormal hyperexcit-
ability of diabetic DRG neurons may be partially mediated by its
suppressive action on INaT.
GAS Restores the Decreased Potassium Currents in Small
DRG Neurons from Diabetic Rats
In addition to sodium currents, potassium currents are also
important for shaping action potentials and controlling neuronal
excitability [13,33,50,51]. In contrast to the well-studied changes
of INaT, the role of potassium currents in the hyperexcitability of
small DRG neurons in diabetic states has rarely been reported.
Although a recent study found that potassium currents were
greatly reduced in dissociated large- and medium-diameter DRG
neurons after STZ injection, changes in potassium currents in
nociceptive small DRG neurons were not observed [17].
Considering the obvious functional differences reported between
dissociated and intact DRG neurons [18,19], we sought to
systematically examine the changes of potassium currents in intact
capsaicin-sensitive small DRG neurons following STZ-induced
diabetes. Our results show that the current densities of total
potassium currents displayed a prominent reduction in diabetic
small DRG neurons compared to control neurons. Further
analysis of the kinetic properties of activation and inactivation
revealed a significant difference between diabetic and control
groups of neurons. Similar downregulation of potassium currents
was also found in other pain conditions [52,53,54,55]. Native
potassium currents in DRG neurons are comprised of two major
types: A-type and sustained delayed rectifier (IK) currents
[16,35,56]. The A-type currents (IA) include both fast inactivating
(IAf) and slowly inactivating (IAS) currents. IAS is activated at
potentials more negative than 240 mV and is characterized by
transient activation and slow inactivation [9,31,35,56]. It has been
shown that IAS plays a key role in regulating repetitive discharges
and excitability [57,58]. Therefore, we isolated IAS and analyzed
the changes in IAS in diabetic rats. We demonstrated that diabetes
caused a notable decrease in IAS in capsaicin-sensitive small DRG
neurons. Furthermore, the kinetic properties of activation and
inactivation of IAS were altered after STZ-induced diabetes. These
results are inconsistent with a recent report by Cao et al, where
they showed no difference in either total potassium or IA currents
in small DRG neurons recorded from diabetic and control groups
[17]. This discrepancy might be due to different preparations and
different protocols for isolation of IA currents used in these two
studies. In the DRG, the potassium channel subtype Kv1.4 was
identified to be the subtype primarily expressed in small-diameter
neurons and was associated with IA in this subgroup of neurons
[15,36,59]. In support of our electrophysiological data, the mRNA
levels of potassium channel subunits, including Kv1.4, Kv3.4,
Kv4.2, and Kv4.3, were significantly reduced in the DRG from
diabetic rats [17].
Another interesting finding of the present study is that GAS
effectively reversed the changes in potassium currents in small
DRG neurons of diabetic rats. The current density of the total
potassium current was greatly increased by GAS in a dose-
dependent manner at a more hyperpolarized membrane potentials
(,220 mV), but decreased at more positive potentials (.10 mV).
However, the exact reason for voltage-dependent regulation of
total potassium current by GAS is not known. GAS also exerts an
obvious influence on the activation kinetics of total potassium
current in diabetic DRG neurons. In contrast, the same doses of
GAS were not effective on the total potassium current in small
DRG neurons from control rats. This indicates that GAS may
selectively act on the potassium currents in pathological pain
states. Similar to the total potassium current, IAS was enhanced by
treatment with GAS in diabetic small DRG neurons at more
hyperpolarized membrane potentials. The activation and inacti-
vation kinetics of IAS were markedly affected by GAS as well.
However, which subtypes of potassium channels that could be
potential targets of GAS remains to be clarified. Interestingly,
GAS only changed the potassium currents in capsaicin-sensitive
DRG neurons, but not in capsaicin-insensitive small DRG
neurons. Thus, the relationship between GAS, potassium channels
and TRPV1 receptors remains to be investigated. It should be
noted that TRPV1-expressing neurons are not the only target of
GAS, the effect of GAS on other types of neurons such as A-type
DRG neurons can not be excluded. Our preliminary data on
single fiber recordings showed that GAS could diminish the
spontaneous activity of A-type fibers from compressed DRG
neurons (unpublished data). The inhibition of GAS on both
capsaicin-sensitive C-type DRG neurons and A-type DRG
neurons may collectively be responsible for the analgesic action
on allodynia and hyperalgesia associated with diabetes. Further
observation of GAS on A-type DRG neurons remains to be
investigated.
In summary, the present study, for the first time, systematically
evaluated the role of GAS in an experimental rat model of STZ-
induced painful diabetic neuropathy and explored its underlying
mechanisms. Our results revealed a strong analgesic effect of GAS
on the allodynia and hyperalgesia induced by STZ injection in
rats. This analgesia in diabetic rats is partially mediated by
diminishing the abnormal hypersensitivity of capsaicin-sensitive
small DRG neurons by GAS. Reciprocal regulation of the
enhanced INaT and decreased potassium currents in diabetic small
DRG neurons contributes to the depression of GAS on the
neuronal excitability. Taken together, this study provides a clear
cellular basis for the analgesic action of GAS in the periphery in
treating chronic pain, including painful diabetic neuropathy.
Materials and Methods
Experimental Animals
Experiments were conducted on adult male Sprague-Dawley
rats weighing 200–250 g. Rats were fasted overnight to maximize
the effectiveness of streptozotocin (STZ) treatment. All experi-
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Protection Committee of the Fourth Military Medical University,
and were in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals (1996
revision). The methods used for obtaining an experimental model
of diabetes have been described elsewhere [10]. In brief, diabetes
mellitus was induced by a single subcutaneous (s.c.) injection of
STZ (Sigma, 70 mg/kg body weight) in ice-cold citrate buffer
(pH 4.5). Age-matched rats in the control group received
injections of citrate buffer. Blood sampled from the tail vein were
measured 48 h after injection, and the onset of diabetic conditions
was defined as glucose levels higher than 16.6 mmol/L (300 mg/
dL). Every effort was made to minimize both animal suffering and
the number of animals used. The rats were maintained in a
diabetic state for a maximum of 4 weeks, and the animals did not
develop significant ketoacidosis or prostration during this time
period [7,8].
Behavioral Testing
All animals were handled extensively and habituated to the test
environment for 1 week prior to testing. Mechanical and thermal
sensitivity were assessed in 4 groups of rats: 1) untreated control
rats, 2) STZ-induced diabetic rats, 3) vehicle treated rats, and 4)
gastrodin (GAS)-treated diabetic rats. To quantify mechanical
sensitivity of the hindpaw, rats were placed in a hanging cage with
a metal mesh floor and tested by manual application of von Frey
filaments to the plantar surface of hindpaw. Each filament of any
given force was applied 10 times and paw withdrawal response
frequency (the percentage of positive responses to the stimulus) was
recorded. The force of filament to elicit 50% frequency of paw
withdrawal was defined as the mechanical threshold [39,60]. To
quantify thermal sensitivity of the hindpaw, rats were placed in a
clear Plexiglass chamber (15 cm620 cm615 cm) located on an
elevated clear glass platform (2 mm thick) and tested with
application of radiant heat to the plantar surface of hindpaw (Iitc
Life Science). The radiant heat source was a high intensity
projector halogen lamp bulb (100 W) positioned under the glass
floor directly beneath the targeting area on the hindpaw. The
distance between the projector lamp bulb and the lower surface of
the glass floor was adjusted to produce a light spot on the floor
surface that was 2–3 mm in diameter. The heat stimulus was
directed onto the plantar surface of the hindpaw of each rat. Five
stimuli to the same site were repeated and the inter-stimulus
interval was 10 min at the same hindpaw, 5 min at the different
hindpaw. The thermal latency was determined automatically from
the device, since hindpaw withdrawal resulted in a cut-off of the
heat stimulus. To avoid excessive tissue damage, the heat stimulus
was limited to a 50 s duration. The mean thermal latency was
computed by averaging the 5 measurements [61,62].
GAS was dissolved in 0.9% sterile saline and injected
intraperitoneally after the 12
th day of STZ treatment, and then
once a day for the next 12 days at doses of 5, 10, 20 mg/kg body
weight.
Intact DRG Preparation and Electrophysiological
Recording
Rats were anesthetized with 1% pentobarbital sodium (50 mg/
kg body weight, i.p.), and the L4 and L5 DRGs were carefully
removed from the vertebral column and placed into an artificial
cerebrospinal fluid maintained at 4uC (ACSF, see below for
composition). After cleaning the connective tissue, the ganglia
were digested with a mixture of 0.4 mg/ml trypsin (Sigma) and
1.0 mg/ml type-A collagenase (Sigma) for 40 min at 37uC while
being oxygenated by gentle bubbling with 95% O2 and 5% CO2.
After digestion, the ganglia were transferred into ACSF and
incubated at 28uC with mixed gas [63].
The intact DRGs were incubated in ACSF at 28uC for at least
1 h before being placed into the recording chamber. During
recording, the ganglia were kept in position by a small anchor and
submerged in a chamber filled with external solution that was
saturated with mixed gas. The temperature was maintained at 26–
28uC. DRG neurons were visualized with a 40x water-immersion
objective attached to a BX51WI microscope (Olympus, Tokyo,
Japan) equipped with infrared differential interference contrast
optics. Whole-cell recording was performed with an Axon 200B
amplifier (Molecular Devices, USA). Patch pipettes (4–7 MV)
were pulled from borosilicate glass capillaries using a two-stage
vertical puller (model PP-83, Narishige, Tokyo, Japan), which gave
a series resistance of ,10 MV. All junction potentials were
corrected online by adjusting the pipette offset using the 200B
Commander software (Molecular Devices). Voltage errors were
minimized using 80–90% series resistance compensation, and the
capacitance artifact was canceled with by the patch-clamp
amplifier. Linear leakage currents were digitally subtracted offline.
Neurons were selected for further study if they had a resting
membrane potential more negative than 250 mV and exhibited
an overshooting action potential [10,63,64]. Recordings were
obtained from a total of 193 DRG neurons and included 87 cells
from control rats (n=24 rats) and 106 cells from diabetic rats
(n=36 rats).
The ACSF contained (in mM): 124 NaCl, 2.5 KCl, 1.2
NaH2PO4, 1.0 MgCl2, 2.0 CaCl2, 25 NaHCO3 and 10 Glucose.
The internal pipette solution for current-clamp recording and
potassium current measurements contained (in mM): 140 KCl, 2
MgCl2, 10 HEPES, 2 Mg-ATP (pH 7.4, adjusted by KOH).
Osmolarity was adjusted to 290–300 mOsm by sucrose. The
transient sodium current was recorded in a special bath solution
that contained a lower concentration of sodium ions. The bath
solution used for sodium current recordings was composed of (in
mM): 65 NaCl, 30 tetraethylammonium-Cl, 45 Choline-Cl, 0.1
CaCl2, 5 MgCl2, 0.1 CdCl2, 10 HEPES, 11 glucose. The pH was
adjusted to 7.4 by NaOH and the osmolarity was 300 mOsm. The
electrodes were filled with (in mM): 100 CsCl, 30 tetraethylam-
monium-Cl, 5 NaCl, 2 MgCl2, 0.1 CaCl2, 3 EGTA, 10 HEPES, 2
Mg-ATP (pH 7.4, adjusted by CsOH, 290–300 mOsm). The bath
solution for measuring potassium current contained (in mM): 140
Choline-Cl, 5 KCl, 2.0 CaCl2, 1.0 MgCl2, 10 HEPES, 1 CdCl2,
10 glucose, 1 mM tetrodotoxin (TTX) (pH 7.4, adjusted by KOH,
300 mOsm).
Data were acquired with a Digidata 1322A acquisition system
(Molecular Devices) using pCLAMP 10.0 software. Signals were
low-pass filtered at 2 kHz, sampled at 10 kHz and analyzed
offline. For analysis of active membrane properties, membrane
potential was held at 260 mV under current-clamp mode.
Depolarizing current steps 5 ms in duration were applied in
20 pA increments to detect the AP threshold; current steps 500 ms
in duration and 50 pA increments were used to measure the other
kinetics of a single spike, i.e., the latency to the first spike and firing
frequency. The AP threshold was determined by differentiating
the AP waveform and setting a rising rate of 10 mV/ms as the AP
inflection point. The AP amplitude was measured from the
equipotential point of the threshold to the spike peak. The AP
duration was measured at the half-width of the spike. Rise and
decay slopes were detected from the AP threshold to the peak. The
current amplitude was converted into conductance using Ohm’s
law: G = I/(V-ENa), where V is the test potential and ENa is the
Na
+ equilibrium potential calculated using the Nernst equation.
Conductance was normalized and fitted with a Boltzmann
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half-activation voltage, and k is the slope factor. The concentra-
tion-response curves were fitted by the Hill equation: fi =1/
(1+[IC50/C]h), where IC50 is the half-maximal effective concen-
tration. Fittings of the rising phase of all types of currents were
performed by an exponential function raised to the power of two:
fi =A [1-exp(-t/t)]
2, where t is the activation time constant. The
decaying phase of the currents was fitted by a single-exponential
(for Na
+ current) or double exponential (for K
+ current) function:
A1exp(-t/t1)+A2exp(-t/t2).
Drugs were applied by bath superfusion with a change in
solutions in the recording chamber, being complete within 3 min.
The drugs used were GAS, capsaicin and TTX. The stock
solutions of GAS (500 mg/5 ml), TTX (10 mM), and capsaicin
(2 mM) were prepared with sterile saline, distilled water, and
DMSO, respectively, and then diluted to the desired concentration
in the external recording solution immediately before use. All
chemicals were obtained from Sigma (St. Louis, MO, USA).
Histology
The recorded neurons were filled by biocytin (0.5%) contained
in the pipette solution. After whole-cell recordings, the DRGs
containing biocytin-filled neurons were fixed overnight in a cold
solution containing 4% paraformaldehyde in 0.1 M phosphate
buffer (PB), and cryoprotected in 30% sucrose in 0.1 M PB at 4uC
until the tissue sank to the bottom of the container. Transverse
DRG sections (14 mm) were cut on a cryostat (Leica) and mounted
serially on slides. To visualize expression of the transient receptor
potential vanilloid 1 (TRPV1), double immunofluorescence
labeling methods were used. Briefly, the sections were rinsed
twice with 0.1 M PB and then incubated with a solution
containing 0.3% Triton X-100 and 1% bovine serum albumin
(BSA) for 3 h at room temperature. The sections then were
incubated with polyclonal anti-TRPV1 (1:1000, Sigma raised in
rabbit) antibodies for 24 h at 4uC. After three washes with PBST
(10 min each wash), the sections were further incubated with
secondary antibodies Alexa Fluor 488 conjugated goat anti-rabbit
IgG (1:500, Invitrogen) and TRITC-labeled streptavidin (1:500,
Sigma) for 2 h at room temperature. The sections were then
mounted with anti-fade medium and stored at 4uC. All images
were captured with an Olympus confocal microscope.
Statistical Analysis
All results are presented as the mean 6 SEM. Student’s t-test or
the analysis of variance (ANOVA) for random measures followed
by post-hoc Fisher’s test or Dunnett’s test was used to determine
statistically significant differences. P,0.05 was considered to be
significant.
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